Structure Therapeutics, Inc. Sponsored ADR (GPCR)
NASDAQ:GPCR
Want to see GPCR full AI Analyst Report?
GPCR Analyst Ratings
Strong Buy
15 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
GPCR Stock 12 Month Forecast
Average Price Target
$110.69
▲(118.11% Upside)
| Highest Price Target$145.00 | Average Price Target$110.69 | Lowest Price Target$90.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
H.C. Wainwright
$100
Buy
97.04%
Upside
Reiterated
05/12/26
LifeSci Capital
$104
Buy
104.93%
Upside
Assigned
05/09/26
Canaccord Genuity
$101
Buy
99.01%
Upside
Reiterated
05/08/26
Cantor Fitzgerald
$101
Buy
99.01%
Upside
Reiterated
05/08/26
Guggenheim
$140
Buy
175.86%
Upside
Reiterated
05/07/26
William Blair
―
Buy
―
Reiterated
05/07/26
BMO Capital
$130→$145
Buy
185.71%
Upside
Reiterated
03/16/26
Goldman Sachs
$102→$101
Buy
99.01%
Upside
Reiterated
03/16/26
Citi
$100
Buy
97.04%
Upside
Reiterated
03/16/26
J.P. Morgan
―
Buy
―
Reiterated
03/16/26
Piper Sandler
$93
Buy
83.25%
Upside
Reiterated
02/27/26
Citizens JMP
$120→$113
Buy
122.66%
Upside
Reiterated
02/27/26
Stifel Nicolaus
$90
Buy
77.34%
Upside
Reiterated
02/27/26
Morgan Stanley
$125→$126
Buy
148.28%
Upside
Reiterated
02/27/26
Jefferies
$125
Buy
146.31%
Upside
Reiterated
02/27/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
$100
Buy
97.04%
Upside
Reiterated
05/12/26
LifeSci Capital
$104
Buy
104.93%
Upside
Assigned
05/09/26
Canaccord Genuity
$101
Buy
99.01%
Upside
Reiterated
05/08/26
Cantor Fitzgerald
$101
Buy
99.01%
Upside
Reiterated
05/08/26
Guggenheim
$140
Buy
175.86%
Upside
Reiterated
05/07/26
William Blair
―
Buy
―
Reiterated
05/07/26
BMO Capital
$130→$145
Buy
185.71%
Upside
Reiterated
03/16/26
Goldman Sachs
$102→$101
Buy
99.01%
Upside
Reiterated
03/16/26
Citi
$100
Buy
97.04%
Upside
Reiterated
03/16/26
J.P. Morgan
―
Buy
―
Reiterated
03/16/26
Piper Sandler
$93
Buy
83.25%
Upside
Reiterated
02/27/26
Citizens JMP
$120→$113
Buy
122.66%
Upside
Reiterated
02/27/26
Stifel Nicolaus
$90
Buy
77.34%
Upside
Reiterated
02/27/26
Morgan Stanley
$125→$126
Buy
148.28%
Upside
Reiterated
02/27/26
Jefferies
$125
Buy
146.31%
Upside
Reiterated
02/27/26
Best Analysts Covering Structure Therapeutics, Inc. Sponsored ADR
3 Months
xxx
Success Rate
9/17 ratings generated profit
Average Return
+14.06%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 52.94% of your transactions generating a profit, with an average return of +14.06% per trade.
1 Year
Success Rate
9/13 ratings generated profit
Average Return
+50.28%
Copying Ananda Ghosh's trades and holding each position for 1 Year would result in 69.23% of your transactions generating a profit, with an average return of +50.28% per trade.
2 Years
xxx
Success Rate
9/13 ratings generated profit
Average Return
+32.74%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 69.23% of your transactions generating a profit, with an average return of +32.74% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
GPCR Analyst Recommendation Trends
Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
17
14
19
18
17
Buy
11
15
11
8
4
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
28
29
30
26
21
Each month's total comprises the sum of three months' worth of ratings.
GPCR Financial Forecast
GPCR Stock Forecast FAQ
What is GPCR’s average 12-month price target, according to analysts?
Based on analyst ratings, Structure Therapeutics, Inc. Sponsored ADR’s 12-month average price target is 110.69.
What is GPCR’s upside potential, based on the analysts’ average price target?
Structure Therapeutics, Inc. Sponsored ADR has 118.11% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is GPCR a Buy, Sell or Hold?
Structure Therapeutics, Inc. Sponsored ADR has a consensus rating of Strong Buy which is based on 15 buy ratings, 0 hold ratings and 0 sell ratings.
What is Structure Therapeutics, Inc. Sponsored ADR’s price target?
The average price target for Structure Therapeutics, Inc. Sponsored ADR is 110.69. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $145.00 ,the lowest forecast is $90.00. The average price target represents 118.11% Increase from the current price of $50.75.
The highest analyst price target is $145.00 ,the lowest forecast is $90.00. The average price target represents 118.11% Increase from the current price of $50.75.
What do analysts say about Structure Therapeutics, Inc. Sponsored ADR?
Structure Therapeutics, Inc. Sponsored ADR’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Streets Analysts.
How can I buy shares of GPCR?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.